The stock of GoHealth Inc (GOCO) closed the regular trading session at $1.2, gaining 11.63% from the previous day’s session. GOCO stock remained bullish in the regular trading session. On the last check, the stock of GOCO plummeted in the after-hours and lost 4.17% to $1.15. The company released the fiscal performance for Q4 and FY21. The stock rating was also downgraded by the analyst at RBC Capital. Later in December 2022, the company also reported affectation awards under Nasdaq Listing Rule.

GoHealth is a commercial center for Medicare plans including Medicare Advantage, Medigap, and Medicare. It additionally works a web-based medical coverage commercial center contribution individual health care coverage and short-term health care coverage. The company has a market capitalization of $385.85 million. Also, GOCO has its headquarter in Chicago, Illinois, USA.

GOCO News

In December 2021, the company declared that it has given the 2021 inducement award to the Chief Financial Officer, Vance Johnston. The instigation awards were supported by a greater part of the organization’s autonomous chiefs. The incitement awards comprised of a non-legal choice to buy a total of 0.438 million stocks of the organization, and 0.281 million confined stock units of the organization. The stock had a price of $3.55 for each stock, and a term of ten years for each stock.

GOCO Financials

Also, GOCO released the fiscal performance for Q4 and FY21, which concluded on 31 December 2021. The company had total sales of $449.6 million in Q4 of FY21 versus $445.9 million in the same year-ago period. This marks an expansion of 0.82% in the total sales. Also, the firm’s total sales in FY2021 saw a growth of 21% to $1.06 billion compared to $877.3 million in FY2020.

Moreover, GOCO reported a total loss of $432.3 million in Q4 of FY2021 against the total income of $133.1 million in the corresponding period of last year. Besides, GOCO’s total loss in FY2021 expanded by 449.5% to $534.1 million against $97.2 million in FY2020.

Further, GoHealth had a loss of $1.35 per stock in Q4 of FY2021 compared to the EPS of $0.41 in Q4 of FY2020. Not only but also, the company reported a loss of $1.79 per stock in FY2021 versus the loss of $0.22 per stock in FY2020.

FY2022 Stance

GoHealth estimates the total sales for FY2022 to be in the range of $900 million to $1.1 billion.

What does the analyst say?

The analyst at RBC Capital downgraded the stock rating from outperform to sector perform, lowering the target price from $10 to $2.